Genetic structure of IDDM1: Two separate regions in the major histocompatibility complex contribute to susceptibility or protection

Diabetes

Volumn 47, Issue 2, 1998, Pages 263-269

  Moghaddam, P Hanifi ^a   De Knijf, P ^b   Roep, B O ^a   Van der Auwera, B ^c   Naipal, A ^a   Gorus, F ^c   Schuit, F ^c   Giphart, M J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLELE; ARTICLE; AUTOIMMUNITY; CHROMOSOME MAP; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0031911947     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.2.263     Document Type: Article

References (55)

1. Nepom GT, Erlich H: MHC class II molecules and autoimmunity. Ann Rev Immunol 9:493-525, 1991
2. Sheehy MJ: HLA and insulin-dependent diabetes: a protective perspective (Review). Diabetes 41:123-129, 1992
3. Todd JA: Genetic control of autoimmunity in type 1 diabetes. Immunol Today 11:122-129, 1990
4. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SO, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Bain SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136, 1994
5. + seropositive juvenile rheumatoid arthritis. J Exp Med 164:345-350, 1986
6. Sheehy MJ, Scharf SJ, Rowe JR, Neme de Gimenez MH, Meske M, Erlich HA, Nepom BS: A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invent 83:830-835, 1989
7. Todd JA, Mijovic C, Fletcher J, Jenkins D, Bradwell AR, Barnett AH: Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 338:587-589, 1989
8. Deng GY, Muir A, Maclaren NK, She JX: Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet 56:528-534, 1995
9. Platz P, Jakobsen BK, Morling N, Ryder LP, Svejgaard A, Thomson A, Christy M, Kromann H, Benn J, Nerup J, Green A, Hauge M: HLA-D and -DR antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetologia 21:108-115, 1981
10. Wolf E, Spencer KM, Cudworth AG: The genetic susceptibility to type 1 diabetes: analysis of the HLA-DR association. Diabetologia 24:224-230, 1983
11. Thomson G, Robinson WP, Kuhner MK, Jos S, MacDonald MJ, Gottschall JL, Barbosa J, Rich SS, Bertrams J, Baur Mp: Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus (Review). Am J Hum Genet 43:799-816, 1988
12. Knip M, Ilonen J, Mustonen A, Åkerblom HK: Evidence of an accelerated β-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes. Diabetologia 29:347-351, 1986
13. Ronningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E: Distribution of HLA-DRB1, -DQA1, and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 37:105-111, 1991
14. Baisch JM, O'Brien ME, Hoover ML, Capra JD: Analysis of HLA genotypes and susceptibility to insulin-dependent diabetes mellitus: HLA-DQ-α complements HLA-DQ-β. Scand J Immunol 36:321-330, 1992
15. Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I, Bougneres P, Bach JF: Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242-2250, 1992
16. Heimberg H, Nagy ZP, Somers G, De Leeuw I, Schuit FC: Complementation of HLA-DQA and -DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus. Hum Immunol 33:10-17, 1992
17. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA-DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years: the Belgian Diabetes Registry. Diabetotogia 36:1155-1162, 1993
18. Van der Auwera B, Waeyenberge CV, Schuit F, Heimberg H, Vandewalle C, Gorus F, Flament J, the Belgian Diabetes Registry: DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Diabetes 44:527-330, 1995
19. She JX Susceptibility to type 1 diabetes: HLA-DQ and -DR revisited. Immunol Today 17:333-339, 1996
20. Undlien DE, Friede T, Rammensee HG, Joner G, Dahl-Jørgensen K, Søvik O, Akselen HE, Knutsen I, Rønningen KS, Thorsby E: HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 46:143-149, 1997
21. Hanifi Moghaddam P, Zwinderman AH, de Knijf P, Roep BO, Schipper RF, Van de Auwera B, Naipal A, Gorus F, Schuit F, Giphart MJ, the Belgian Diabetes Registry: TNF-α microsatellite polymorphism modulates risk for IDDM in Caucasians with the high-risk genotype HLA-DQA1*0501-DQB1*0201/DQA1*0301-DQB1*0302. Diabetes 46:1514-1515, 1997
22. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissete J, Weissenbach J: A comprehensive genetic map of the human genome based on 5,264 microsatel lites. Nature 380:152-154, 1996
23. Don RH, Wainwright BJ, Bakker K, Mattick JS: "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res 19:4008, 1991
24. Guo SW, Thomson EA: Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361-372, 1992
25. Long JC, Williams RC, Urbanek M: An E-M algorithm and testing strategy for multiple locus haplotypes. Am J Hum Genet 56:799-810, 1995
26. Ceppellini R, Siniscalco M, Smith CAB: The estimation of gene frequencies in a random mating population. Ann Hum Genet 20:97-115, 1955
27. Smith CAB: Counting methods in genetical statistics. Ann Hum Genet 21:245-276, 1957
28. Dempster AP, Laird NM, Rubin DB: Maximum likelihood from incomplete data via the EM algorithm. J Roy Stat Soc B 39:1-38, 1977
29. Ott J: Counting methods (EM algorithm) in human pedigree analysis: linkage and segregation analysis. Am J Hum Genet 51:283-290, 1977
30. Baur MP, Danilovs JA: Population analysis of HLA-A,B,DR and other genetic markers. In Histocompatibility Testing 1980. Terasaki PI, Ed. Los Angeles, CA, UCLA, 1980
31. Goddard KAB, Yu CE, Oshima J, Miki T, Nakura J, Piussan C, Martin GM, Schellenberg GD, Wijsman EM, International Werner's Syndrome Collaborative Group: Toward localization of the Werner syndrome gene by linkage disequilibrium and ancestral haplotyping: lessons learned from analysis of 35 chromosome 8p11.1-21.1 markers. Am J Hum Genet 58:1286-1302, 1996
32. Vandewalle CL, Coeckelberghs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry: Epidemiology, clinical aspects, and the biology of IDDM patients under age 40 years: comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. Diabetes Care. 20:1556-1561, 1997
33. Tuomilehto J: Diabetes - a problem for millions of people and their families in the European Union. Diabetologia 40 (Suppl. Augustus):12-14, 1997
34. Solver RH, Eisenbarth GS: Prevention of type 1 diabetes and recurrent β-cell destruction of transplanted cells. Endocr Rev 17:241-258, 1997
35. Excoffier L, Langaney A: Origin and differentiation of human mitochondrial DNA. Am J Hum Genet 44:73-75, 1989
36. Excoffier L, Smouse PE, Quattro JM: Analysis of molecular variance inferred from metric distance among DNA haplotypes: application to human mitochondrial DNA restriction data Genetics 131:479-491, 1992
37. Excoffier L, Smouse PE: Using allele frequencies and geographic subdivision to reconstruct gene trees within a species: molecular variance parsimony. Genetics 136:343-359, 1994
38. Freimer NB, Slatkin M: Microsatellites: evolution and mutational processes: variation in the human genome. Ciba Found Symp 197:51-71, 1996
39. Kashi Y, King D, Soller M: Simple sequence repeats as a source of quantitative genetic variation. TIG 13:74-78, 1997
40. Degli-Esposti MA, Abraham LJ, McCann V, Spies T, Christiansen FT, Dawkins RL: Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics 36:345-356, 1992
41. Raum D, Awdeh ZL, Yunis EJ, Alper CA, Gabby KH: Extended major histocompatibility complex haplotypes in type 1 diabetes mellitus. J Clin Invest 74:449-459, 1984
42. Saueracker G, Christiansen FT, Dawkins RL: Pulsed field gel electrophoresis demonstrates the gene organization within diabetogenic ancestral haplotypes: possible location of MHC genes influencing susceptibility to IDDM. In Diabetes 1988. Larkins R, Zimmet P, Chisholm D, Eds. New York. Elsevier, 1988, p. 379-382
43. Dawkins RL, Zhang WJ, Degli-Esposti MA, Abraham LJ, McCann V, Christiansen FT: Studies of haplotypes by pulsed field gel electrophoresis. In Bailliere's Clinical Endocrinology and Metabolism: The Genetics of Diabetes. Tain B, Harrison L, Eds. London, Bailliere Tindall, 1991, p. 285-298
44. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tusi LC: Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080, 1989
45. Weber JL, Wong C: Mutation of human short tandem repeats. Am J Hum Genet 2:1123-1128, 1989
46. Levinson G, Gutman GA: Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol Biol Evol 4:203-221, 1987
47. Delépine M, Pociot F, Habita C, Hashimoto L, Froguel P, Rotter J, Cambon-Thomsen A, Dechamps I, Djoulah S, Weissenbach J, Nerup J, Lathrop M, Julier C: Evidence of a non-MHC susceptibility locus in type 1 diabetes linked to HLA on chromosome 6. Am J Hum Genet 60:174-187, 1997
48. Levo A, Westman P, Partanen J: An approach to mapping haplotype-specific recombination sites in human MHC class III. Immunogenetics 43:130-140, 1996
49. Steinmetz M, Stephan D, Lindahl KF: Gene organization and recombinational hot spots in the murine major histocompatibility complex. Cell 44:895-904, 1986
50. Kobori JA, Strauss E, Minard K, Hood L: Molecular analysis of the hot spots of recombination in the murine major histocompatibility complex. Science 234:173-179, 1986
51. Uematsu Y, Lindhal KF, Steinmetz M: The same MHC recombination hot spots are active in crossing-over between wild/wild and wild/inbred mouse chromosomes. Immunogenetics 27:96-101, 1988
52. Shiroishi T, Sagai T, Moriwaki K: Hot spots of meiotic recombination in the mouse major histocompatibility complex. Genetica 88:187-196, 1993
53. Thomsen M, Neugebauer M, Arnaud J, Borot N, Sevin A, Baur M, Cambon-Thomsen A: Recombination fractions in the HLA system based on the data set "Provence Francaises": indications of haplotype specific recombination rates. Euro J Immunogenetics 21:33-34, 1994
54. Martin M, Mann D, Carrington M: Recombination rates across the HLA complex: use of microsatellites as a rapid screen for recombinant chromosomes. Hum Mol Genet 4:423-428, 1995
55. Pociot F, Briant L, Jongeneel CV, Molvig J, Worsaae H, Abbal M, Thomsen M, Nerup J: Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mono nuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 23:224-231, 1993